Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | STK17B | O94768 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL67624 | 0.81 | RET (0.41) | RETKDRSTK17BCYP19A1MAOB | |
| SCHEMBL92288 | 0.81 | ESR1 (0.45) | RETKDRSTK17BCYP19A1MAOB | |
| SCHEMBL8702376 | 0.81 | ESR1 (0.45) | RETKDRSTK17BCYP19A1MAOB | |
| SCHEMBL9434848 | 0.81 | ESR1 (0.45) | RETKDRSTK17BCYP19A1MAOB | |
| SCHEMBL69430 | 0.76 | PARP1 (0.48) | RETKDRSTK17BCYP19A1MAOB | |
| SCHEMBL15188492 | 0.75 | MAOB (0.39) | RETKDRCYP19A1MAOBKDM4E | |
| SCHEMBL18885280 | 0.75 | CYP19A1 (0.47) | RETKDRCYP19A1MAOBKDM4E | |
| SCHEMBL21371327 | 0.75 | CYP19A1 (0.47) | RETKDRCYP19A1MAOBKDM4E | |
| SCHEMBL31015940 | 0.74 | RET (0.41) | RETKDRSTK17BCYP19A1MAOB | |
| SCHEMBL5579742 | 0.73 | ESR1 (0.56) | RETKDRCYP19A1MAOBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2682272-B1 | INK JET RECORDING METHOD AND PRINTED MATERIAL | FUJIFILM CORP (JP) | 2015-08-26 | — | — | EP | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-7985785-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2011-07-26 | — | — | US | disclosed |
| US-20100015360-A1 | AQUEOUS INK COMPOSITION, AQUEOUS INK COMPOSITION FOR INKJET RECORDING, AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2010-01-21 | — | — | US | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20080239045-A1 | INK SET FOR INKJET RECORDING AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20080182031-A1 | Sensitizing dye, an alpha-aminoketone or acyl phosphine oxide polymerization initiator and an ethylenically unsaturated bond-containing polymerizable compound | FUJIFILM CORPORATION (JP) | 2008-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | RB1, IK, NOX1 | RET 755/4885KDR 2861/4885STK17B 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.